An Observational Multicenter Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System In Pseudophakic Eyes With Primary Open Angle Glaucoma (ORION 2.0)

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

November 2, 2023

Study Completion Date

November 2, 2023

Conditions
Glaucoma, Open-Angle
Interventions
DEVICE

OMNI® Surgical System

The OMNI® Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm's canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma.

Trial Locations (10)

23502

Virginia Eye Consultants, Norfolk

30315

Eye Specialists of Georgia, Atlanta

37803

University Eye Specialists, Maryville

55431

Minnesota Eye Consultants, Bloomington

62708

Grene Vision Group, Wichita

73112

Oklahoma Eye Surgeons, Oklahoma City

76102

Ophthalmology Associates - Fort Worth, Fort Worth

79902

El Paso Eye Surgeons, El Paso

84403

Utah Eye Centers, Ogden

07079

Northern New Jersey Eye Institute, Orange

All Listed Sponsors
lead

Sight Sciences, Inc.

INDUSTRY